Loading...

Robert Parmer

TitleSenate Emeritus
InstitutionUniversity of California San Diego
DepartmentMedicine
Address9500 Gilman Drive #9111-H
La Jolla CA 92093
Phone858-552-8585
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Regulation of Renal Injury and Fibrosis by the Plasminogen Receptor, Plg-RKT
    VA I01BX003933Apr 1, 2018 - Mar 31, 2022
    Role: Principal Investigator
    Cell Surface Plasminogen Activation and Hypertension
    VA I01BX002026Apr 1, 2013 - Mar 31, 2017
    Role: Principal Investigator
    PROCESSING OF CHROMOGRANIN A BY THE FIBRINOLYTIC SYSTEM
    NIH/NHLBI R01HL050398Sep 1, 1994 - Jun 30, 2005
    Role: Principal Investigator
    AUTONOMIC AND RENAL PHENOTYPES IN BLACK PEDIGREES
    NIH/NHLBI R01HL050174Sep 30, 1992 - Sep 29, 1995
    Role: Principal Investigator
    CHROMOGRANIN
    NIH/NHLBI K11HL001416Jul 1, 1984 - Jun 30, 1990
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Miles LA, Parmer R. tPA and anger management for macrophages. Blood. 2017 09 14; 130(11):1280-1281. PMID: 28912293.
      View in: PubMed
    2. Briens A, Bardou I, Lebas H, Miles LA, Parmer R, Vivien D, Docagne F. Astrocytes regulate the balance between plasminogen activation and plasmin clearance via cell-surface actin. Cell Discov. 2017; 3:17001. PMID: 28417010.
      View in: PubMed
    3. Miles LA, Parmer R. Angry macrophages patrol for fibrin. Blood. 2016 Mar 03; 127(9):1079-80. PMID: 26941388; PMCID: PMC4778160 [Available on 03/03/17].
    4. Miles LA, Parmer R. Setting the table for macrophages. Blood. 2014 Jul 31; 124(5):665-6. PMID: 25082858; PMCID: PMC4118476.
    5. Miles LA, Lighvani S, Baik N, Parmer CM, Khaldoyanidi S, Mueller BM, Parmer R. New insights into the role of Plg-RKT in macrophage recruitment. Int Rev Cell Mol Biol. 2014; 309:259-302. PMID: 24529725; PMCID: PMC4060795.
    6. Miles LA, Parmer R. Plasminogen receptors: the first quarter century. Semin Thromb Hemost. 2013 Jun; 39(4):329-37. PMID: 23532575; PMCID: PMC3938387.
    7. Miles LA, Plow EF, Waisman DM, Parmer R. Plasminogen receptors. J Biomed Biotechnol. 2012; 2012:130735. PMID: 23226936; PMCID: PMC3511834.
    8. Bai H, Nangia S, Parmer R. The plasminogen activation system and the regulation of catecholaminergic function. J Biomed Biotechnol. 2012; 2012:721657. PMID: 23097598; PMCID: PMC3477892.
    9. Miles LA, Lighvani S, Baik N, Andronicos NM, Chen EI, Parmer CM, Khaldoyanidi S, Diggs JE, Kiosses WB, Kamps MP, Yates JR, Parmer R. The plasminogen receptor, Plg-R(KT), and macrophage function. J Biomed Biotechnol. 2012; 2012:250464. PMID: 23125524; PMCID: PMC3484331.
    10. Félez J, Jardí M, Fàbregas P, Parmer R, Miles LA. Monoclonal antibodies against receptor-induced binding sites detect cell-bound plasminogen in blood. Blood. 2012 Jul 19; 120(3):678-81. PMID: 22649107; PMCID: PMC3401219.
    11. Lighvani S, Baik N, Diggs JE, Khaldoyanidi S, Parmer R, Miles LA. Regulation of macrophage migration by a novel plasminogen receptor Plg-R KT. Blood. 2011 Nov 17; 118(20):5622-30. PMID: 21940822; PMCID: PMC3217361.
    12. Bai H, Baik N, Kiosses WB, Krajewski S, Miles LA, Parmer R. The novel plasminogen receptor, plasminogen receptor(KT) (Plg-R(KT)), regulates catecholamine release. J Biol Chem. 2011 Sep 23; 286(38):33125-33. PMID: 21795689; PMCID: PMC3190921.
    13. Han J, Baik N, Kim KH, Yang JM, Han GW, Gong Y, Jardí M, Castellino FJ, Felez J, Parmer R, Miles LA. Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen. Blood. 2011 Aug 11; 118(6):1653-62. PMID: 21680799; PMCID: PMC3156051.
    14. Jiang Q, Gingles NA, Olivier MA, Miles LA, Parmer R. The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles. Blood. 2011 Jun 30; 117(26):7155-63. PMID: 21596853; PMCID: PMC3143556.
    15. Miles LA, Parmer R. S100A10: a complex inflammatory role. Blood. 2010 Aug 19; 116(7):1022-4. PMID: 20724548.
      View in: PubMed
    16. Miles LA, Parmer R. PAI-1: cardiac friend or foe? Blood. 2010 Mar 11; 115(10):1862-3. PMID: 20223930.
      View in: PubMed
    17. Andronicos NM, Chen EI, Baik N, Bai H, Parmer CM, Kiosses WB, Kamps MP, Yates JR, Parmer R, Miles LA. Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation. Blood. 2010 Feb 18; 115(7):1319-30. PMID: 19897580; PMCID: PMC2826757.
    18. Gutiérrez-Fernández A, Gingles NA, Bai H, Castellino FJ, Parmer R, Miles LA. Plasminogen enhances neuritogenesis on laminin-1. J Neurosci. 2009 Oct 07; 29(40):12393-400. PMID: 19812315; PMCID: PMC2789650.
    19. Miles LA, Andronicos NM, Baik N, Parmer R. Cell-surface actin binds plasminogen and modulates neurotransmitter release from catecholaminergic cells. J Neurosci. 2006 Dec 13; 26(50):13017-24. PMID: 17167091.
      View in: PubMed
    20. Etzel JP, Rana BK, Wen G, Parmer R, Schork NJ, O'Connor DT, Insel PA. Genetic variation at the human alpha2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response. Hypertension. 2005 Jun; 45(6):1207-13. PMID: 15920038.
      View in: PubMed
    21. Miles LA, Hawley SB, Baik N, Andronicos NM, Castellino FJ, Parmer R. Plasminogen receptors: the sine qua non of cell surface plasminogen activation. Front Biosci. 2005 May 01; 10:1754-62. PMID: 15769664.
      View in: PubMed
    22. Le Corre P, Parmer R, Kailasam MT, Kennedy BP, Skaar TP, Ho H, Leverge R, Smith DW, Ziegler MG, Insel PA, Schork NJ, Flockhart DA, O'connor DT. Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism. Clin Pharmacol Ther. 2004 Aug; 76(2):139-53. PMID: 15289791.
      View in: PubMed
    23. Lee JC, Taylor CV, Gaucher SP, Toneff T, Taupenot L, Yasothornsrikul S, Mahata SK, Sei C, Parmer R, Neveu JM, Lane WS, Gibson BW, O'Connor DT, Hook VY. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells. Biochemistry. 2003 Jun 17; 42(23):6938-46. PMID: 12795588.
      View in: PubMed
    24. Wong CM, O'Connor DT, Martinez JA, Kailasam MT, Parmer R. Diminished renal kallikrein responses to mineralocorticoid stimulation in African Americans: determinants of an intermediate phenotype for hypertension. Am J Hypertens. 2003 Apr; 16(4):281-9. PMID: 12670744.
      View in: PubMed
    25. Taupenot L, Harper KL, Mahapatra NR, Parmer R, Mahata SK, O'Connor DT. Identification of a novel sorting determinant for the regulated pathway in the secretory protein chromogranin A. J Cell Sci. 2002 Dec 15; 115(Pt 24):4827-41. PMID: 12432071.
      View in: PubMed
    26. Jiang Q, Yasothornsrikul S, Taupenot L, Miles LA, Parmer R. The local chromaffin cell plasminogen/plasmin system and the regulation of catecholamine secretion. Ann N Y Acad Sci. 2002 Oct; 971:445-9. PMID: 12438162.
      View in: PubMed
    27. Taupenot L, Harper KL, Mahapatra NR, Parmer R, O'Connor DT. Intracellular protein trafficking into catecholamine storage vesicles: novel chimeric photoproteins visualized by deconvolution fluorescence microscopy. Ann N Y Acad Sci. 2002 Oct; 971:262-5. PMID: 12438129.
      View in: PubMed
    28. Parmer R, Zinder O. Catecholaminergic pathways, chromaffin cells, and human disease. Ann N Y Acad Sci. 2002 Oct; 971:497-505. PMID: 12438170.
      View in: PubMed
    29. Miles LA, Hawley SB, Parmer R. Chromaffin cell plasminogen receptors. Ann N Y Acad Sci. 2002 Oct; 971:454-9. PMID: 12438164.
      View in: PubMed
    30. O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer R. The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension. Ann N Y Acad Sci. 2002 Oct; 971:533-5. PMID: 12438176.
      View in: PubMed
    31. Bannach FG, Gutierrez A, Fowler BJ, Bugge TH, Degen JL, Parmer R, Miles LA. Localization of regulatory elements mediating constitutive and cytokine-stimulated plasminogen gene expression. J Biol Chem. 2002 Oct 11; 277(41):38579-88. PMID: 12149246.
      View in: PubMed
    32. O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer R. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens. 2002 Jul; 20(7):1335-45. PMID: 12131530.
      View in: PubMed
    33. Zhang L, Seiffert D, Fowler BJ, Jenkins GR, Thinnes TC, Loskutoff DJ, Parmer R, Miles LA. Plasminogen has a broad extrahepatic distribution. Thromb Haemost. 2002 Mar; 87(3):493-501. PMID: 11916082.
      View in: PubMed
    34. Parmer R, Mahata M, Gong Y, Mahata SK, Jiang Q, O'Connor DT, Xi XP, Miles LA. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion. J Clin Invest. 2000 Oct; 106(7):907-15. PMID: 11018079; PMCID: PMC381423.
    35. Parmer R, Mahata M, Mahata S, Sebald MT, O'Connor DT, Miles LA. Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA. J Biol Chem. 1997 Jan 17; 272(3):1976-82. PMID: 8999889.
      View in: PubMed